Elumalai, Rajasegaran and Patil, Shilpa and Maliyakkal, Naseer and Rangarajan, Annapoorni and Kondaiah, Paturu and Raichur, Ashok M (2015) Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers. In: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 11 (4). pp. 969-981.
PDF
Nano_Med_Nano_Tech_Bio_and med_11-969-2015.pdf - Published Version Restricted to Registered users only Download (2MB) | Request a copy |
Abstract
Multidrug resistance is a major therapeutic challenge faced in the conventional chemotherapy. Nanocarriers are beneficial in the transport of chemotherapeutics by their ability to bypass the P-gp efflux in cancers. Most of the P-gp inhibitors under phase II clinical trial are facing failures and hence there is a need to develop a suitable carrier to address P-gp efflux in cancer therapy. Herein, we prepared novel protamine and carboxymethyl cellulose polyelectrolyte multi-layered nanocapsules modified with Fe3O4 nanoparticles for the delivery of doxorubicin against highly drug resistant HeLa cells. The experimental results revealed that improved cellular uptake, enhanced drug intensity profile with greater percentage of apoptotic cells was attained when doxorubicin loaded magnetic nanocapsules were used in the presence of external magnetic field. Hence, we conclude that this magnetic field assisted nanocapsule system can be used for delivery of chemotherapeutics for potential therapeutic efficacy at minimal dose in multidrug resistant cancers. From the Clinical Editor: Many cancer drugs fail when cancer cells become drug resistant. Indeed, multidrug resistance (MDR) is a major therapeutic challenge. One way that tumor cells attain MDR is by over expression of molecular pumps comprising of P-glycoprotein (P-gp) and multidrug resistant proteins (MRP), which can expel chemotherapeutic drugs out of the cells. In this study, the authors prepared novel protamine and carboxymethyl cellulose polyelectrolyte multi-layered nanocapsules modified with Fe3O4 nanoparticles for the delivery of doxorubicin. The results show that there was better drug delivery and efficacy even against MDR tumor cells. (C) 2015 Elsevier Inc. All rights reserved.
Item Type: | Journal Article |
---|---|
Publication: | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE |
Publisher: | ELSEVIER SCIENCE BV |
Additional Information: | Copy right for this article belongs to the ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS |
Keywords: | Magnetic nanocapsules; Drug resistant cells; Doxorubicin delivery; Apoptosis; Targeted delivery |
Department/Centre: | Division of Biological Sciences > Molecular Reproduction, Development & Genetics Division of Mechanical Sciences > Materials Engineering (formerly Metallurgy) |
Date Deposited: | 16 Jun 2015 05:23 |
Last Modified: | 16 Jun 2015 05:23 |
URI: | http://eprints.iisc.ac.in/id/eprint/51701 |
Actions (login required)
View Item |